CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Sale | −80,909 | $12.81 | $1.0M | 0 |
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +76,182 | $1.08 | $82K | 76,182 |
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Sale | −76,182 | $12.81 | $976K | 0 |
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −80,909 | 85,293 | ||
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −76,182 | 228,548 | ||
| 2023-08-11 | Congleton Jon Chief Executive Officer | Purchase | +2,000 | $12.89 | $26K | 1,040,318 |
| 2023-08-10 | Rodman David Malcom Chief Medical Officer | Option exercise | +74,625 | $0.54 | $40K | 74,625 |
| 2023-08-10 | Rodman David Malcom Chief Medical Officer | Sale | −74,625 | $13.16 | $982K | 0 |
| 2023-08-10 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −74,625 | 166,202 | ||
| 2023-07-12 | Takahashi Takeshi Director | Other disposition · Stock Option | −44,000 | 0 | ||
| 2023-07-12 | Slingsby Brian Taylor Director | Other disposition · Stock Option | −44,000 | 0 | ||
| 2023-07-12 | Slingsby Brian Taylor Director | Other acquisition · Stock Option | +88,000 | 88,000 | ||
| 2023-04-27 | Litzka Olivier Director | Other disposition · Stock Option | −44,000 | 0 | ||
| 2023-03-17 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2023-03-17 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +99,800 | 99,800 | ||
| 2023-03-17 | Levy Adam Scott CFO and Secretary | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2023-02-14 | Levy Adam Scott CFO, Chief Bus. Off. and Secy. | Purchase | +6,250 | $16.00 | $100K | 350,811 |
| 2023-02-14 | AKKARAJU SRINIVAS Director | Conversion | +3,581,861 | 3,581,861 | ||
| 2023-02-14 | AKKARAJU SRINIVAS Director | Purchase | +937,500 | $16.00 | $15.0M | 4,519,361 |
| 2023-02-14 | AKKARAJU SRINIVAS Director | Conversion · Series A Preferred Stock | −2,135,504 | 0 |
Page 21 of 23 · 446 trades